BACKGROUND: The main goal of the present study was to assess the influence of the androgen receptor gene CAG repeat polymorphism on hyperandrogenism and its phenotypical features in patients with polycystic ovary syndrome (PCOS). METHODS: CAG repeat lengths were analyzed in 97 oligo-anovulatory women with ultrasound features of PCOS. All individuals were assessed for endocrine parameters and their phenotypical features were recorded. These parameters were correlated with the CAG repeat lengths. RESULTS: PCOS patients with a bi-allelic mean lower than 21 repeats had lower dihydrotestosterone levels (p = 0.007), lower androstenedione levels (p = 0.023), lower luteinizing hormone levels (p = 0.023), a lower luteinizing hormone/follicle-stimulating hormone ratio (p = 0.021) and the highest percentage of patients with acne and/or hirsutism (p = 0.021). CONCLUSIONS: Our findings support the hypothesis that the PCOS phenotype may result from either elevated androgen levels or an enhanced sensitivity to androgens caused by a more active androgen receptor.
BACKGROUND: The main goal of the present study was to assess the influence of the androgen receptor gene CAG repeat polymorphism on hyperandrogenism and its phenotypical features in patients with polycystic ovary syndrome (PCOS). METHODS: CAG repeat lengths were analyzed in 97 oligo-anovulatory women with ultrasound features of PCOS. All individuals were assessed for endocrine parameters and their phenotypical features were recorded. These parameters were correlated with the CAG repeat lengths. RESULTS:PCOSpatients with a bi-allelic mean lower than 21 repeats had lower dihydrotestosterone levels (p = 0.007), lower androstenedione levels (p = 0.023), lower luteinizing hormone levels (p = 0.023), a lower luteinizing hormone/follicle-stimulating hormone ratio (p = 0.021) and the highest percentage of patients with acne and/or hirsutism (p = 0.021). CONCLUSIONS: Our findings support the hypothesis that the PCOS phenotype may result from either elevated androgen levels or an enhanced sensitivity to androgens caused by a more active androgen receptor.
Authors: Cui Ying Peng; Hui Jun Xie; Zi Fen Guo; Yu Lin Nie; Jun Chen; Jun Mei Zhou; Jie Yin Journal: J Assist Reprod Genet Date: 2014-07-02 Impact factor: 3.412
Authors: Michelle Y Abshire; Susan K Blank; Sandhya Chhabra; Christopher R McCartney; Christine A Eagleson; John C Marshall Journal: Endocrine Date: 2011-11-13 Impact factor: 3.633
Authors: Armin Raznahan; Yohan Lee; Reva Stidd; Robert Long; Dede Greenstein; Liv Clasen; Anjene Addington; Nitin Gogtay; Judith L Rapoport; Jay N Giedd Journal: Proc Natl Acad Sci U S A Date: 2010-09-14 Impact factor: 11.205
Authors: Aline Ketefian; Michelle R Jones; Ronald M Krauss; Yii-Der I Chen; Richard S Legro; Ricardo Azziz; Mark O Goodarzi Journal: Fertil Steril Date: 2015-10-20 Impact factor: 7.329
Authors: Shilpi Dasgupta; Pisapati V S Sirisha; Kudugunti Neelaveni; Kathragadda Anuradha; Alla G Reddy; Kumarasamy Thangaraj; B Mohan Reddy Journal: PLoS One Date: 2010-08-26 Impact factor: 3.240